Abstract P1-14-04: A Randomized Phase II Neoadjuvant (NACT) Study of Sequential Eribulin Followed by FAC/FEC-regimen Compared to Sequential Paclitaxel Followed by FAC/FEC-regimen in Patients (pts) with Operable Breast Cancer Not Overexpressing HER-2
Cancer Research(2016)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要